Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics

Blood (2023) 142 (Supplement 1): 163.

https://doi.org/10.1182/blood-2023-186367

Published: 2023

Journal Articles

Targeting PLZF Enhances Glucocorticoid Sensitivity in Acute Myeloid Leukemia

Azadeh Hajmirza, Laura Simon, Jalila Chagraoui, Nadine Mayotte, Jean-François Spinella, Tara Macrae, Bernhard Lehnertz, Thierry Bertomeu, Jasmin Coulombe-Huntington, Geneviève Boucher, Sébastien Lemieux, Mike Tyers, Josee Hebert, Guy Sauvageau

Blood (2022) 140 (Supplement 1): 8825–8826.

https://doi.org/10.1182/blood-2022-163685

Published: 2022

Journal Articles

High frequency of germline RUNX1 mutations in patients with RUNX1 -mutated AML

Laura Simon, Jean-François Spinella, Chi-Yuan Yao, Vincent-Philippe Lavallée, Isabel Boivin, Geneviève Boucher, Eric Audemard, Marie-Eve Bordeleau, Sébastien Lemieux, Josée Hébert, Guy Sauvageau

Blood (2020) 135 (21): 1882–1886.

https://doi.org/10.1182/blood.2019003357

Published: 2020

Includes: Supplemental data

Journal Articles

Genetic Characterization of ABT-199 Sensitivity in Human AML

Marie-Eve Bordeleau, PhD, Richard Bisaillon, PhD, Clarisse Thiollier, PhD, Jana Krosl, PhD, Bernhard Lehnertz, PhD, Vincent-Philippe Lavallee, MD, Tara MacRae, Labelle Caroline, Geneviève Boucher, Isabel Boivin, Giovanni D'Angelo, Sylvie Lavallée, Anne Marinier, PhD, Sébastien Lemieux, PhD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2018) 132 (Supplement 1): 283.

https://doi.org/10.1182/blood-2018-99-113062

Published: 2018

Journal Articles

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 910.

https://doi.org/10.1182/blood-2018-99-114525

Published: 2018

Journal Articles

Chemogenomic Approach Unveils the Increased Susceptibility of RUNX1 -Mutated AML to Glucocorticoids

Laura Simon, BSc, MSc, Vincent-Philippe Lavallee, MD, Marie-Eve Bordeleau, PhD, Bernhard Lehnertz, PhD, Tara MacRae, Jalila Chagraoui, PhD, Jean-Francois Spinella, PhD, Geneviève Boucher, Thierry Bertomeu, PhD, Jasmin Coulombe-Huntington, PhD, Mike Tyers, PhD, Sébastien Lemieux, PhD, Anne Marinier, PhD, Josée Hébert, MD, Guy Sauvageau, MD PhD

Blood (2018) 132 (Supplement 1): 4675.

https://doi.org/10.1182/blood-2018-99-111030

Published: 2018

Journal Articles

Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease

Vincent-Philippe Lavallée, MD, Miriam Marquis, PhD, Marie-Ève Bordeleau, PhD, Jalila Chagraoui, PhD, Tara MacRae, M.Sc., Isabel Boivin, M.Sc, Geneviève Boucher, M.Sc, Patrick Gendron, M.Sc, Sébastien Lemieux, PhD, Arnaud Bonnefoy, PhD, Georges E. Rivard, MD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2016) 128 (22): 1075.

https://doi.org/10.1182/blood.V128.22.1075.1075

Published: 2016

Journal Articles

Chemo-Transcriptomic Analysis of Complex Karyotype AML Reveals Increased Expression of Cell Cycle Components and Exquisite Dependency on Polo-like Kinase 1

Vincent-Philippe Lavallée, MD, Clarisse Thiollier, PhD, Céline Moison, PhD, Marie-Ève Bordeleau, PhD, Isabel Boivin, M.Sc, Geneviève Boucher, M.Sc, Patrick Gendron, M.Sc, Sébastien Lemieux, PhD, Anne Marinier, PhD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2016) 128 (22): 769.

https://doi.org/10.1182/blood.V128.22.769.769

Published: 2016

Journal Articles

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors

Vincent-Philippe Lavallée, Jana Krosl, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Caroline Pabst, Isabel Boivin, Anne Marinier, Cynthia J. Guidos, Sylvain Meloche, Josée Hébert, Guy Sauvageau

Blood (2016) 127 (24): 3054–3061.

https://doi.org/10.1182/blood-2016-03-705053

Published: 2016

Includes: Supplemental data

Journal Articles

RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature

Vincent-Philippe Lavallée, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Isabel Boivin, Richard N. Armstrong, Guy Sauvageau, Josée Hébert

Blood (2016) 127 (20): 2498–2501.

https://doi.org/10.1182/blood-2016-03-703868

Published: 2016

Includes: Supplemental data

Journal Articles

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo

Blood (2016) 127 (16): 2018–2027.

https://doi.org/10.1182/blood-2015-11-683649

Published: 2016

Includes: Supplemental data

Journal Articles

The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia

Caroline Pabst, MD, Anne Bergeron, PhD, Vincent-Philippe Lavallée, MD, Jonathan Yeh, PhD, Patrick Gendron, M.Sc, Jana Krosl, PhD, Geneviève Boucher, M.Sc, Sébastien Lemieux, PhD, Josee Hébert, MD, Guy Sauvageau, MD, PhD, Frédéric Barabé, MD

Blood (2015) 126 (23): 1859.

https://doi.org/10.1182/blood.V126.23.1859.1859

Published: 2015

Journal Articles

Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements

Vincent-Philippe Lavallée, MD, Patrick Gendron, M.Sc, Geneviève Boucher, M.Sc, Sébastien Lemieux, PhD, Richard Neil Armstrong, PhD, Isabel Boivin, M.Sc, Guy Sauvageau, MD, PhD, Josée Hébert, MD

Blood (2015) 126 (23): 802.

https://doi.org/10.1182/blood.V126.23.802.802

Published: 2015

Journal Articles

NGS-Based Detection Of Multiple RAS -Mutated Clones In MLL -Rearranged Leukemias Suggests Strong Oncogenic Collaboration

Vincent-Philippe Lavallée, MD, Patrick Gendron, M.Sc., Geneviève Boucher, M.Sc., Marianne Arteau, M.Sc., Brian T Wilhelm, Ph.D., Sébastien Lemieux, Ph.D., Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2013) 122 (21): 744.

https://doi.org/10.1182/blood.V122.21.744.744

Published: 2013

Journal Articles

Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation

Fanny Guimont-Desrochers, Geneviève Boucher, Zhongjun Dong, Martine Dupuis, André Veillette, Sylvie Lesage

Blood (2012) 119 (19): 4349–4357.

https://doi.org/10.1182/blood-2011-11-395954

Published: 2012

Includes: Supplemental data

Journal Articles

RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity

Brian T. Wilhelm, Mathieu Briau, Pamela Austin, Amélie Faubert, Geneviève Boucher, Pierre Chagnon, Kristin Hope, Simon Girard, Nadine Mayotte, Josette-Renee Landry, Josée Hébert, Guy Sauvageau

Blood (2011) 117 (2): e27–e38.

https://doi.org/10.1182/blood-2010-07-293332

Published: 2011

Includes: Supplemental data

NARROW

Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics

Targeting PLZF Enhances Glucocorticoid Sensitivity in Acute Myeloid Leukemia

High frequency of germline RUNX1 mutations in patients with RUNX1 -mutated AML

Genetic Characterization of ABT-199 Sensitivity in Human AML

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia

Chemogenomic Approach Unveils the Increased Susceptibility of RUNX1 -Mutated AML to Glucocorticoids

Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease

Chemo-Transcriptomic Analysis of Complex Karyotype AML Reveals Increased Expression of Cell Cycle Components and Exquisite Dependency on Polo-like Kinase 1

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors

RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo

The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia

Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements

NGS-Based Detection Of Multiple RAS -Mutated Clones In MLL -Rearranged Leukemias Suggests Strong Oncogenic Collaboration

Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation

RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only